XBiotech Inc Stock Prediction
AI-powered sentiment analysis and prediction trends for XBIT, updated each market day.
XBIT AI Sentiment
AI sees no strong directional signal for XBiotech Inc stock over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About XBiotech Inc
XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.
Sector
Exchange
Market Cap
$71,036,413
Cap Tier
Employees
85
Headquarters
AUSTIN, TX
Listed Since
April 15, 2015
Website
XBIT Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
XBIT Volatility
XBiotech Inc has shown moderate price volatility over the last 5 trading days. Moderate volatility indicates normal market activity with typical price fluctuations.
